Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth: A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease

Some experimental studies have suggested a beneficial effect of the mammalian target of rapamycin (mTOR) inhibitor use on hepatic and renal cyst growth in patients with autosomal dominant polycystic kidney disease (ADPKD). However, the results of clinical studies are conflicting and the role of mTOR...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedrich, L., Barbey, F., Pascual, M., Venetz, J.-P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530859/
https://www.ncbi.nlm.nih.gov/pubmed/23304619
http://dx.doi.org/10.1155/2012/513025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530859/
https://www.ncbi.nlm.nih.gov/pubmed/23304619
http://dx.doi.org/10.1155/2012/513025

Ejemplares similares